High prevalence of self-reported autism spectrum disorder in the Propionic Acidemia Registry

Maria L Cotrina1, Sindy Ferreiras2, Patricia Schneider2

  • 1Propionic Acidemia Foundation (PAF) Highland Park Illinois.

JIMD Reports
|February 20, 2020
PubMed

Insights

Propionic Acidemia (PA), a metabolic disorder, shows a notable prevalence of autism spectrum disorders (ASD). ASD in PA patients is diagnosed later and is gender-balanced, suggesting unique disease-related risk factors.

Area of Science:

  • Biochemistry
  • Genetics
  • Neurology

Background:

  • Propionic Acidemia (PA) involves toxic propionic acid buildup, causing multi-organ damage, including neurological effects.
  • Autism Spectrum Disorders (ASD) are observed in some children with Propionic Acidemia, indicating a potential link.

Purpose of the Study:

  • To investigate the prevalence and characteristics of ASD in individuals with Propionic Acidemia.
  • To compare ASD diagnosis age and gender distribution in PA patients with general autism populations.

Main Methods:

  • Data compilation from 62 individuals in the Propionic Acidemia International Patient Registry.
  • Comparison of registry data with published literature on autism prevalence in PA.

Main Results:

  • A significant proportion of PA patients in the registry have ASD diagnoses, consistent with literature findings.
  • ASD in PA patients is gender-balanced and diagnosed at a later median age (8 years) compared to the national autism registry (4.3 years).

Conclusions:

  • The findings suggest potential PA-specific risk factors influencing ASD development and presentation.
  • Patient registries are valuable for rare disease research, but increased participation and data consistency are needed.

Related Concept Videos